The Cancer Biopsy Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Cancer Biopsy Market?
The market size for cancer biopsy has experienced swift expansion in the past few years. The market is projected to increase from $25.08 billion in 2024 to $28.52 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 13.7%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Cancer Biopsy Industry?
The Cancer Biopsy Global Market Report 2025 forecasts that the size of the market will reach $47.2 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 13.4%.
Download Your Free Sample of the 2025 Cancer Biopsy Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Cancer Biopsy Market?
The key drivers in the cancer biopsy market are:
• Surge in the global elderly population and increase in cancer cases
• Rising number of individuals suspected of having breast cancer
• Technological advancements and AI integration in biopsy testing
• Emergence of point-of-care biopsy devices and product innovations
Global Market Segmentation: Identifying Major Cancer Biopsy Industry Segments
The cancer biopsymarket covered in this report is segmented –
1) By Type: Tissue Biopsies, Liquid Biopsies, Other Types
2) By Application: Breast Cancer, Colorectal Cancer, Cervical Cancers, Lung Cancers, Prostate Cancers, Skin Cancers, Blood Cancers, Kidney Cancers, Other Applications
3) By End User: Hospitals, Diagnostic Laboratories, Other End Users
Pre-order the 2025 Cancer Biopsy Global Market Report for Fast Delivery & Comprehensive Insights!
What are the emerging Trends Shaping the Future of the Cancer Biopsy Market?
The key trends in the cancer biopsy market are:
• Technological advancements are becoming a major trend in the cancer biopsy market.
• The integration of artificial intelligence and machine learning is increasingly shaping the market.
• The market's future is also guided by a trend towards the integration of multi-omics.
• It is expected that the market will be influenced by product innovation and the adoption of point-of-care biopsy devices.
Who Are the Top Competitors & Leading Players in the Cancer Biopsy Market?
Major companies in the cancer biopsy market are:
• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Becton Dickinson and Company
• Roche Diagnostics GmbH
• Hologic Inc.
• Illumina Inc.
• Bio-Rad Laboratories Inc.
• QIAGEN N.V.
• Exact Sciences Corporation
• Myriad Genetics Inc.
• Guardant Health Inc.
• Veracyte Inc.
• GRAIL Inc.
• Freenome Holdings Inc.
• Biodesix Inc.
• Chronix Biomedical Inc.
• Biocept Inc.
• Personal Genome Diagnostics Inc.
• Agena Bioscience Inc.
• Oncimmune Holdings plc
• Exosome Diagnostics Inc.
• Epigenomics AG
• Genesystems Inc.
• Lucence Diagnostics Pte. Ltd.
• ANGLE plc
Regional Dominance: Which Area Leads the Global Cancer Biopsy Market?
North America was the largest region in the cancer biopsy market in 2024
